Search

Daniels, Anthony, Michael Sandberg, Jianjun Chen, Carol Weigel-DiFranco, Fielding Hejtmancic, and Eliot Berson. 2012. “Genotype-Phenotype Correlations in Bardet-Biedl Syndrome”. Arch Ophthalmol 130 (7): 901-7.

Swaminathan, Swarup, Dong-Jin Oh, Min Hyung Kang, Ruiyi Ren, Rui Jin, Haiyan Gong, and Douglas Rhee. 2013. “Secreted Protein Acidic and Rich in Cysteine (SPARC)-Null Mice Exhibit More Uniform Outflow”. Invest Ophthalmol Vis Sci 54 (3): 2035-47.

Van Tyne, Daria, Melissa Martin, and Michael Gilmore. 2013. “Structure, Function, and Biology of the Enterococcus Faecalis Cytolysin”. Toxins (Basel) 5 (5): 895-911.

Yiu, Glenn, Kyle Marra, Sushant Wagley, Sheela Krishnan, Harpal Sandhu, Kyle Kovacs, Mark Kuperwaser, and Jorge Arroyo. 2013. “Surgical Outcomes After Epiretinal Membrane Peeling Combined With Cataract Surgery”. Br J Ophthalmol 97 (9): 1197-201.

Yonekawa, Yoshihiro, John Miller, Angela Turalba, and Dean Eliott. 2013. “Traumatic Macular Hole from Intentional Basketball Overinflation”. Ophthalmic Surg Lasers Imaging Retina 44 (3): 303-5.

Amparo, Francisco, Zahra Sadrai, Yiping Jin, Belen Alfonso-Bartolozzi, Haobing Wang, Hasanain Shikari, Joseph Ciolino, et al. 2013. “Safety and Efficacy of the Multitargeted Receptor Kinase Inhibitor Pazopanib in the Treatment of Corneal Neovascularization”. Invest Ophthalmol Vis Sci 54 (1): 537-44.

Baris, Hagit, Wai-Man Chan, Caroline Andrews, Doron Behar, Diana Donovan, Cynthia Morton, Judith Ranells, Tuya Pal, Azra Ligon, and Elizabeth Engle. 2013. “Complex Cytogenetic Rearrangements at the DURS1 Locus in Syndromic Duane Retraction Syndrome”. Clin Case Rep 1 (1).

Baxter, Sally, Maxwell Pistilli, Siddharth Pujari, Teresa Liesegang, Eric Suhler, Jennifer Thorne, Stephen Foster, et al. 2013. “Risk of Choroidal Neovascularization Among the Uveitides”. Am J Ophthalmol 156 (3): 468-477.e2.

Chen, Jing, and Lois Smith. 2013. “Altered Cholesterol Homeostasis in Aged Macrophages Linked to Neovascular Macular Degeneration”. Cell Metab 17 (4): 471-2.

D’Amato, Robert, Suzanne Lentzsch, and Michael Rogers. 2013. “Pomalidomide Is Strongly Antiangiogenic and Teratogenic in Relevant Animal Models”. Proc Natl Acad Sci U S A 110 (50): E4818.